Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Decompensated Non-Alcoholic Steatohepatitis Cirrhosis”

3 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 3 of 3 results

Testing effectiveness (Phase 2)Ended earlyNCT03827200
What this trial is testing

A Study Evaluating the Utility of Ambrisentan in Lowering Portal Pressure in Patients With Liver Cirrhosis

Who this might be right for
CirrhosisPortal HypertensionAscites
Noorik Biopharmaceuticals AG 19
Not applicableEnded earlyNCT03479125
What this trial is testing

Post-Treatment Follow-up Study for Liver Disease Subjects With or Without Cirrhosis After Receiving Emricasan or Placebo

Who this might be right for
Liver DiseasesLiver FibrosisLiver Cirrhosis+3 more
Conatus Pharmaceuticals Inc. 40
Testing effectiveness (Phase 2)UnknownNCT03205345
What this trial is testing

Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis

Who this might be right for
Decompensated Cirrhosis
Conatus Pharmaceuticals Inc. 210